Adia Nutrition Inc. has appointed Dawn Bell as Chief Revenue Officer through its subsidiary, ADIA Labs. Bell brings over 15 years of experience in sales strategy within the medical device and pharmaceutical sectors. She will focus on driving growth and supporting physicians and clinics in integrating ADIA's regenerative therapies and diagnostic services.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 279724) on January 08, 2026, and is solely responsible for the information contained therein.